Cargando…
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma
Lower-grade glioma (LGG) is a group of tumors arising from the cells of the central nervous system. Although various therapy interventions are used, the prognosis remains different. Novel biomarkers are needed for the prognosis of disease and novel therapeutic strategies in LGG. The procollagen-lysi...
Autores principales: | Gong, Siming, Wu, Changwu, Köhler, Franziska, Meixensberger, Jürgen, Schopow, Nikolas, Kallendrusch, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894330/ https://www.ncbi.nlm.nih.gov/pubmed/35250490 http://dx.doi.org/10.3389/fncel.2022.838548 |
Ejemplares similares
-
A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3)
por: Gong, Siming, et al.
Publicado: (2021) -
Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion
por: Xu, Yangyang, et al.
Publicado: (2017) -
Correction: Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion
por: Xu, Yangyang, et al.
Publicado: (2021) -
A tumor microenvironment-based prognostic index for osteosarcoma
por: Wu, Changwu, et al.
Publicado: (2023) -
Exome sequencing identifies procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 mutations in primary congenital and juvenile glaucoma
por: Gupta, Viney, et al.
Publicado: (2021)